Skip to main content

Effective Interventions

Core Elements & Fact Sheet

About PrEP

CDC recommends PrEP as an HIV prevention strategy. PrEP has been proven safe and effective in adults and adolescents weighing at least 77 lbs to prevent the acquisition of HIV infection through sexual contact and sharing of uncleaned injection equipment. In July 2012, the FDA approved the combination pill, emtricitabine and tenofovir disoproxil fumarate, or Truvada®, for use as HIV PrEP. Taking Truvada® every day, as prescribed, reduces the risk of getting HIV from sex by more than 90% and reduces the risk of getting HIV by over 70% among people who inject drugs.

The PrEP care system is the system of PrEP delivery for HIV-negative persons who are at risk of HIV infection. Health departments, community-based organizations, and healthcare organizations can form partnerships to support PrEP delivery within this system to prevent HIV infection in high-risk populations.

PrEP is more than a pill. Delivery of PrEP in the United States includes a system of prevention and support services, or the PrEP care system, that contributes to making PrEP available, accessible, and acceptable. The PrEP care system is the system of PrEP delivery for HIV-negative persons who are at risk of HIV infection. Health departments, community-based organizations, and healthcare organizations can form partnerships to support PrEP delivery within this system to prevent HIV infection in high-risk populations.

These web pages provide information and resources to support PrEP as an HIV prevention strategy for health departments, community-based organizations, and healthcare organizations in the United States. 

Additional Information

HIP Project Contact Info:    Phone: 1-(866) 532-9565 or (240) 645-1756    E-mail: interventions@dlhcorp.com
© Copyright 2018 Effective Interventions    View Our Privacy Policy